News
All NewsBlogs
Media
All VideosCase-Based Roundtable SeriesEichenbaum AcornsExpert InterviewsEyeviewsInsightsMedical World NewsPodcastsRapid ReadoutsThe Retina TL;DRViewpoints
Conference
Conference CoverageConference Listing
Publications
Modern Retina Digital EditionSupplements And Featured Publications
More
Resources
Between the LinesCME/CEEYLEA 8mg for nAMD and DME TreatmentSponsored Resources
Partners

Subscribe

  • News
    • All News
    • Blogs
  • Media
    • Conference
      • Publications
        • Resources
          • Partners
          • Subscribe
          • AMD
            • Wet AMD
          • Biosimilar
          • Diabetic Macular Edema
            • Diabetic Eye Awareness
          • Diabetic Retinopathy
          • Geographic Atrophy
          • Imaging
          • Inherited Retinal Diseases
          • Ophthalmology
            • Europe
          • RVO
          • Retina Technology
          • Retinal Surgery
          • Uveitis
          Spotlight -
          Geographic Atrophy
          Advertisement

          Sebastian Wolf, MD, PhD

          Advertisement

          Articles by Sebastian Wolf, MD, PhD

          Sebastian Wolf, MD, PhD and Sophie Bonnin, MD, PhD, speak about the ACUITY trial for OCS-05, a therapy for acute optic neuritis, during the 2025 EURETINA meeting.

          Two experts present on acute optic neuritis and the ACUITY trial during EURETINA 2025

          ByHattie Hayes,Sebastian Wolf, MD, PhD,Sophie Bonnin, MD, PhD
          October 2nd 2025

          The Eye Care Network spoke with Sebastian Wolf, MD, PhD, and Sophie Bonnin, MD, PhD, who presented new findings from the OCS-05 phase 2 ACUITY trial.

          Advertisement

          Latest Updated Articles



            Advertisement
            Advertisement

            Trending on Modern Retina

            1

            Navigating the maze: Establishing novel endpoints for IRD trials

            2

            Eichenbaum Acorns: A leadership conversation with Rishi P. Singh, MD, FASRS, on advancing CME

            3

            Positive pediatric data emerge from the OPGx-LCA5 phase 1/2 trial of Leber congenital amaurosis type 5

            4

            Two experts present on acute optic neuritis and the ACUITY trial during EURETINA 2025

            5

            Anniversary of the spectral OCT prototype: 25 years young and growing

            • About
            • Advertise
            • Editorial
            • Contact Us
            • Terms and Conditions
            • Privacy
            • Do Not Sell My Personal Information
            Contact Info

            259 Prospect Plains Rd, Bldg H
            Monroe, NJ 08831

            609-716-7777

            Brand Logo

            © 2025 MJH Life Sciences®

            All rights reserved.

            Home
            About Us
            News
            Contact Us